Although these studies suggest that both GSK-3α and GSK-3β isoforms are oncogenic in GBM, a tumor suppressor role for GSK-3α has also been proposed in GBM by which it promotes apoptotic alternative splice events [168], though this remains incompletely defined and warrants further investigation. This evidence concerns the gene GSK3A and glioblastoma.